College of Pharmacy
In this section
Podcast Archive
HelixTalk Episode #39 - Diclegis (doxylamine-pyridoxine) and nausea/vomiting of pregnancy
Date posted: February 16, 2016, 6:00 am
In this episode, we discuss nausea and vomiting of pregnancy (NVP) with a particular focus on Diclegis (doxylamine/pyridoxine).
HelixTalk Episode #38 - Suvarexant (Belsomra) - a new drug class for insomnia
Date posted: January 26, 2016, 6:00 am
In this episode, we discuss suvarexant (Belsomra), the first dual orexin receptor antagonist approved in the United States for the treatment of insomnia.
HelixTalk Episode #37 - Understanding Creatinine Clearance
Date posted: January 5, 2016, 6:00 am
In this episode, we have an in-depth review of how to measure glomerular filtration rate (GFR), including variants of the Cockcroft-Gault equation and newer, more accurate methods that may eventually be used to renally adjust certain medications.
HelixTalk Episode #36 - Two new agents for schizophrenia
Date posted: December 15, 2015, 6:00 am
In this episode, we discuss two agents newly approved for schizophrenia -- Rexulti (brexpiprazole) and cariprazine (Vraylar).
HelixTalk Episode #35 - Empagliflozin and dulaglutide
Date posted: November 24, 2015, 6:00 am
In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.
HelixTalk Episode #34 - New Injectable Insulins
Date posted: November 3, 2015, 6:00 am
In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).
HelixTalk Episode #33 - PCSK9 Inhibitors
Date posted: October 13, 2015, 6:00 am
In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).
HelixTalk Episode #32 - ARNIs and Entresto
Date posted: September 22, 2015, 6:00 am
In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.
HelixTalk Episode #31 - Therapeutic Drug Monitoring III
Date posted: September 1, 2015, 6:00 am
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for tacrolimus (Prograf) and lithium.
HelixTalk Episode #30 - Therapeutic Drug Monitoring II
Date posted: August 11, 2015, 6:00 am
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for valproic acid (Depakote/Depakene/Depakon) and digoxin (Lanoxin).